PATTI DARREN JOEL enters TELIX PHARMACEUTICALS LTD with 26.36K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
American Depositary Receipts
DirectOrdinary Shares
Direct| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| American Depositary Receipts | 804.00 | Direct |
| Ordinary Shares | 25.56K | Direct |
| Total | 26.36K | 26.36K direct |
Share Rights
DirectUnderlying shares
12.54K
Shares owned
N/A
Exercise price
0
Expiration
—
Exercise window
—
Performance Share Appreciation Rights (right to buy)
DirectUnderlying shares
27.45K
Shares owned
N/A
Exercise price
6.90
Expiration
—
Exercise window
—
Share Rights
DirectUnderlying shares
15K
Shares owned
N/A
Exercise price
0
Expiration
—
Exercise window
—
Performance Share Appreciation Rights (right to buy)
DirectUnderlying shares
15.83K
Shares owned
N/A
Exercise price
4.95
Expiration
—
Exercise window
—
Share Rights
DirectUnderlying shares
15K
Shares owned
N/A
Exercise price
0
Expiration
—
Exercise window
—
Underlying
85.81K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Share Rights Direct | Ordinary Shares | 0 | — | — | 12.54K | N/A |
| Performance Share Appreciation Rights (right to buy) Direct | Ordinary Shares | 6.90 | — | — | 27.45K | N/A |
| Share Rights Direct | Ordinary Shares | 0 | — | — | 15K | N/A |
| Performance Share Appreciation Rights (right to buy) Direct | Ordinary Shares | 4.95 | — | — | 15.83K | N/A |
| Share Rights Direct | Ordinary Shares | 0 | — | — | 15K | N/A |
| Total | 85.81K | 0.00 | ||||